Arrayit Corporation (ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. - Powerful Science for Life
Corporate - Media & Press - Press Release
Arrayit team wins advertising award.
Sunnyvale, CA, August 7, 2003 – On August 4th Signet Research and PharmaGenomics announced that a recent ArrayIt® advertisement received the highest score of any Life Sciences company, winning by substantial numbers over competing ads by Applied Biosystems, Roche Diagnostics, Invitrogen, Amersham, and BD Biosciences. Mr. Haje’s advertisement appeared in the February 2003 issue of the journal PharmaGenomics, and featured ArrayIt®’s Super Microarray Substrates product line.
Signet Research Inc. was established in 1968 as a full-service marketing research firm specializing in gathering marketing and market information to fit specific client needs. Signet uses a combination of mail and electronic mail surveys, telephone and personal interviews, questionnaires, and focus groups to generate independently derived, object data. PharmaGenomics is an international scientific journal dedicated to serving the genomics, proteomics, drug discovery, and diagnostics communities. Signet performed an independent performance survey of all of the ads in PharmaGenomics, and assigned an AdProbe score of 88% to ArrayIt® compared to lesser scores for Bio-Rad Laboratories (69%), Applied Biosystems (68%), Roche (67%), Invitrogen (66%), Agilent Technologies (66%), Amersham (62%), and BD Biosciences (60%).
Paul Haje, ArrayIt®’s Director of Public Relations and Promotions, was delighted to learn of the Signet award. “My team and I devote a lot of creativity to our print ads, we work closely with the scientific and corporate staff at TeleChem to make sure our ads are technically sound, educational, and appealing. We were satisfied with the ad when it was completed, but had no idea it would achieve the top spot out of all the full-page ads evaluated in the Signet survey. To outperform seven of the world’s most distinguished public companies, having a combined market cap of over $50 billion and a combined advertising budget of over $3 billion - plus the other 21 companies we outperformed - is fantastic.”
TeleChem International is a privately owned high-tech company located in the heart of California’s Silicon Valley. Our products and services are provided by three corporate divisions: ArrayIt® Life Sciences Division, Chemicals Division, and a Diagnostics Division. The ArrayIt® Life Sciences Division offers a complete microarray technology platform that empowers >10,000 laboratories to use microarrays for human genome exploration, basic research, drug discovery, and myriad life sciences applications. Nearly every major research institution uses our patented microarray manufacturing technology (U.S. 6,101,946) and supporting products and services. The Chemicals Division provides import and export services and government contract manufacturing in the area of industrial chemicals for plastics, fire control, water treatment, agriculture, industrial and institutional compounding, and green energy. The Diagnostics Division holds key patents in the United States (6,913,879), Singapore (94899), New Zealand (523560), and other countries for its revolutionary “multi-patient” genotyping technology, which allows as many as 100,000 patients to be tested on a single microarray. Arrayit Diagnostics enables genotyping and disease diagnostics by providing testing kits, services, and technology transfer opportunities for disease screening and testing organizations.
Copyright 1993-2019 Arrayit Corporation. All rights reserved.